Covert and Overt Hepatic Encephalopathy: Diagnosis and Management

被引:154
作者
Patidar, Kavish R.
Bajaj, Jasmohan S. [1 ,2 ]
机构
[1] Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23284 USA
[2] McGuire VA Med Ctr, Richmond, VA USA
关键词
Cirrhosis; Covert Hepatic Encephalopathy; Overt Hepatic Encephalopathy; Hepatic Encephalopathy; Ammonia; Lactulose; Rifaximin; ORNITHINE-L-ASPARTATE; RANDOMIZED CONTROLLED-TRIAL; PORTAL-SYSTEMIC ENCEPHALOPATHY; CRITICAL FLICKER FREQUENCY; CHRONIC LIVER-DISEASE; QUALITY-OF-LIFE; DOUBLE-BLIND; OPEN-LABEL; CIRRHOTIC-PATIENTS; CLINICAL-TRIAL;
D O I
10.1016/j.cgh.2015.06.039
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatic encephalopathy (HE) is part of a spectrum of neurocognitive changes in cirrhosis. HE is divided into 2 broad categories based on severity: covert hepatic encephalopathy (CHE) and overt hepatic encephalopathy (OHE). CHE has a significant impact on a patient's quality of life, driving performance, and recently has been associated with increased hospitalizations and death. Likewise, OHE is associated with increased rates of hospitalizations and mortality, and poor quality of life. Given its significant burden on patients, care takers, and the health care system, early diagnosis and management are imperative. In addition, focus also should be directed on patient and family member education on the disease progression and adherence to medications. Treatment strategies include the use of nonabsorbable disaccharides, antibiotics (ie, rifaximin), and, potentially, probiotics. Other therapies currently under further investigation include L-ornithine-L-aspartate, ornithine phenylacetate, glycerol phenylbutyrate, molecular adsorbent recirculating system, and albumin infusion.
引用
收藏
页码:2048 / 2061
页数:14
相关论文
共 50 条
  • [41] Pathophysiology, diagnosis, and management of hepatic encephalopathy
    Christopher Sheasgreen
    Lucy Lu
    Ameen Patel
    [J]. Inflammopharmacology, 2014, 22 : 319 - 326
  • [42] Pharmacologic Management of Hepatic Encephalopathy
    Khalessi, Ali
    Pyrsopoulos, Nikolaos T.
    [J]. CLINICS IN LIVER DISEASE, 2024, 28 (02) : 287 - 296
  • [43] Covert hepatic encephalopathy leads to distinct alterations in the emotional state, independently of MELD-Score
    Greinert, Robin
    Ripoll, Cristina
    Zipprich, Alexander
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2018, 56 (05): : 461 - 468
  • [44] A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis
    Pantham, Ganesh
    Post, Anthony
    Venkat, Deepak
    Einstadter, Douglas
    Mullen, Kevin D.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (08) : 2166 - 2173
  • [45] Encephalopathy in Cirrhosis: Prevention and Management
    Sahney, Amrish
    Wadhawan, Manav
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (03) : 927 - 936
  • [46] A shortened Stroop test to identify covert hepatic encephalopathy and predict overt hepatic encephalopathy in patients with cirrhosis
    Hanai, Tatsunori
    Nishimura, Kayoko
    Miwa, Takao
    Maeda, Toshihide
    Nakahata, Yuki
    Imai, Kenji
    Suetsugu, Atsushi
    Takai, Koji
    Shimizu, Masahito
    [J]. JOURNAL OF GASTROENTEROLOGY, 2022, 57 (12) : 981 - 989
  • [47] The Diagnosis and Treatment of Minimal Hepatic Encephalopathy
    Zhan, Tianzuo
    Stremmel, Wolfgang
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2012, 109 (10): : 180 - U22
  • [48] A shortened Stroop test to identify covert hepatic encephalopathy and predict overt hepatic encephalopathy in patients with cirrhosis
    Tatsunori Hanai
    Kayoko Nishimura
    Takao Miwa
    Toshihide Maeda
    Yuki Nakahata
    Kenji Imai
    Atsushi Suetsugu
    Koji Takai
    Masahito Shimizu
    [J]. Journal of Gastroenterology, 2022, 57 : 981 - 989
  • [49] Prophylaxis of hepatic encephalopathy: current and future drug targets
    Maharshi, Sudhir
    Sharma, Barjesh Chander
    [J]. HEPATOLOGY INTERNATIONAL, 2024, 18 (04) : 1096 - 1109
  • [50] Efficacy of rifaximin in the different clinical scenarios of hepatic encephalopathy
    Coronel-Castillo, C. E.
    Contreras-Carmona, J.
    Frati-Munari, A. C.
    Uribe, M.
    Mendez-Sanchez, N.
    [J]. REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2020, 85 (01): : 56 - 68